Authors: Andrew M Naidech Monisha A Kumar And the Participants in the International Multidisciplinary Consensus Conference on Multimodality Monitoring
Publish Date: 2014/09/11
Volume: 21, Issue: 2, Pages: 168-176
Abstract
Anemia and bleeding are paramount concerns in neurocritical care and often relate to the severity of intracranial hemorrhage Anemia is generally associated with worse outcomes and efforts to minimize anemia through reduced volume of blood sampled are encouraged Pointofcaretesting reliably detects the use of nonsteroidal antiinflammatory drugs that may worsen bleeding and reduce platelet activity particularly in patients with intracerebral hemorrhage How best to monitor the effect of platelet transfusion or plateletactivating therapy is not well studied For patients known to take novel oral anticoagulants drugspecific coagulation tests before neurosurgical intervention are prudent
Keywords: